Endocrine Abstracts

Introduction: To report the efficacy and safety of intravitreal bevacizumab (avastin) as an adjunctive treatment for proliferative diabetic retinopathy (PDR).Objectives and methods: Thirteen patients (13 eyes) with PDR underwent an intravitreal injection of 1.25 mg of bevacizumab. All patients underwent a complete ophthalmic examination, anterior segment or fundus photographs at baseline and after bevacizumab injection.Results: Ele...